Table 4.

Distribution of CT antigen IHC scoring in patients with stage-III multiple myeloma

mAb/antigenNegative, - (%)Pos (%)Focal, less than 5% (%)+, 5%-25% (%)++, 25%-50% (%)+++, 50%-75% (%)++++, greater than 75% (%)
CT7-33/CT7 6/33 (18) 27/33 (82) 4/33 (12) 4/33 (12) 7/33 (21) 5/33 (15) 7/33 (21)
M3H67/MAGE-A3/6 10/33 (30) 23/33 (70) 5/33 (15) 3/33 (9) 9/33 (27) 3/33 (9) 3/33 (9)
E978/NY-ESO-1 26/33 (79) 7/33 (21) 4/33 (12) 3/33 (9) 0/33 (0) 0/33 (0) 0/33 (0)
  • Results are shown for a total of 33 patients.